Inhibikase Therapeutics is a pharmaceutical company headquartered in Atlanta with additional offices in Boston. We are focused on the development of small-molecule kinase inhibitors for the treatment of neurological infections and neurodegenerative diseases.
For more information regarding our company, partnerships, or drug candidates, please reach out to us using the information provided.
3350 Riverwood Parkway
Atlanta, GA 30339
One Marina Park Drive
Boston, MA 02210